CEO Aaron Erter highlighted strong business results in Q3, with North American EBIT margins reaching 29.1% and a consolidated adjusted net income of $154 million. He emphasized the company’s ability ...
NRG reports its financial results in accordance with the accounting principles generally accepted in the United States (GAAP) and supplements with certain non-GAAP financial measures. These measures ...
CODI reiterates its expectation for full-year 2025 subsidiary Adjusted EBITDA of $330 million to $360 million, excluding ...
CEO Aaron Simons began the call by highlighting that Virtu has completed major integrations, established trading in new asset classes, and returned significant capital to shareholders. Simons stated, ...
Represents expenses and associated changes to estimates related to the prepayment, restructuring, and refinancing of our indebtedness, which are not considered indicative of our ongoing operating ...
Non-GAAP financial measures and ratios. In addition to results reported in accordance with IFRS, the Company uses certain non-GAAP financial measures as supplemental indicators of its financial and ...
Net income increased 136.9% year over year to $75.9 million, a Company record for any quarter Adjusted net income1 increased 41.4% year over year to $40.7 million, a Company record for any quarter ...
Net income increased 106.4% year over year to $32.1 million, a Company record for any quarter Adjusted net income 1 increased 116.2% year over year to $28.8 million, a Company record for any quarter ...
ADMA Biologics reported FY 2024 revenue of $426.5 million, achieving significant increases in net income and adjusted EBITDA. ADMA Biologics, Inc. reported strong financial results for FY 2024, ...
Learn how the Adjusted Net Asset Method refines asset and liability values for accurate fair market valuations, helping in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback